drugset
drugset / Trial / NCT07568405

The Effect of Remifentanil on the Objectively Measured Pressure Pain Threshold

NCT07568405 ↗

Enrolling by invitation 40 enrolled Université Libre de Bruxelles
NaSingle-groupOpen-labelPrevention

Summary

It is a clinical study investigating the relationship between objectively measured pain threshold and the need for escalating doses of remifentanyl opioids. This study is expected to include approximately 40 participants. The aim of the study is to objectively measure the analgesic effect of an increasing dose of opioids just before anesthesia.

Timeline

Start
2026-01-26
Primary completion
2026-06-15
Completion
2026-06-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Remifentanil Small molecule — Intravenous
Background Morphine Other / unclassified 2 mg Intravenous

Indications

No indication recorded.